Sweeping Opioid Lawsuits Don’t Even Get A Mention In McKesson’s Earnings Call
The California-based drug distributor is facing so many other problems -- like a intense public and political anger over high drug prices -- that the opioid lawsuits didn't make a blip.
San Francisco Chronicle:
Drug Giant McKesson Has More Than Just An Opioids Problem
It’s been 18 months since McKesson, the San Francisco pharmaceutical drug distributor — and one of the largest public companies in America — was hit with a record $150 million in fines from the Drug Enforcement Administration for failing to report suspicious orders for controlled substances. ... You’d hardly know it judging by the company’s earnings call Thursday, when the opioids lawsuits — which legal experts say could rival the massive tobacco litigation of the 1990s in scope and settlement dollars — were not mentioned once. (Ho, 7/26)